论文部分内容阅读
目的探讨血液透析联合血液灌流治疗血液透析患者肾性骨病的临床效果。方法 72例血液透析合并肾性骨病患者,按照治疗方法的不同分为研究组(血液透析联合血液灌流治疗)与对照组(血液透析治疗),每组36例。对比两组的治疗效果。结果研究组总有效率为91.7%,高于对照组的69.4%,差异具有统计学意义(P<0.05)。就诊时,研究组患者血钙、血磷、免疫反应性甲状旁腺激素水平与对照组比较差异均无统计学意义(P>0.05);治疗后,研究组血钙水平明显高于对照组,血磷水平、免疫反应性甲状旁腺激素水平明显低于对照组,差异均具有统计学意义(P<0.05)。结论在血液透析合并肾性骨病患者的临床治疗过程中,联合应用血液透析和血液灌流的效果理想,值得进行深入研究和推广。
Objective To investigate the clinical effect of hemodialysis combined with hemoperfusion on hemodialysis patients with renal osteodystrophy. Methods 72 cases of hemodialysis patients with renal osteodystrophy were divided into study group (hemodialysis combined with hemoperfusion therapy) and control group (hemodialysis treatment) according to different treatment methods, 36 cases in each group. Compare the treatment effect of two groups. Results The total effective rate was 91.7% in the study group, which was higher than 69.4% in the control group, the difference was statistically significant (P <0.05). At the time of treatment, the levels of serum calcium, phosphorus and immunoreactive parathyroid hormone in the study group were not significantly different from those in the control group (P> 0.05). After treatment, the serum calcium level in the study group was significantly higher than that in the control group The levels of serum phosphorus and immunoreactive parathyroid hormone were significantly lower than those of the control group, with statistical significance (P <0.05). Conclusions Hemodialysis and hemoperfusion combined with hemodialysis with renal osteodystrophy in clinical treatment of patients with satisfactory results, it is worth carrying out in-depth study and promotion.